CLINICAL_TRIALS
trial_result
· 2019-12-24
Clinical Trial Update: Renal AL Amyloid Involvement and NEOD001 [Phase 2]
Summary
Phase 2 trial evaluating NEOD001 for renal AL amyloidosis was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tufts Medical Center | Conditions: Amyloidosis | Phase 2 | Status: TERMINATED | Results posted: 2019-12-24